Article
[beta-Interferon therapy of chronic hepatitis HCV+, 1b genotype].
Recenti progressi in medicina - 1 May 1998
Vezzoli M, Girola S, Fossati G, Mazzucchelli I, Gritti D, Mazzone A
Abstract excerpt
Various papers reported that chronic viral hepatitis is the principal cause of chronic liver disease, as cirrhosis and hepatocarcinoma. Interferon is the only agent known to have a beneficial effect in chronic hepatitis. The response rate has been less than 10 percent in patients with genotype 1b, but in patients with genotype 2 or 3 it has been greater than 40 percent. Aim of our investigation was to study 10...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
